Literature DB >> 24549834

The clinical course of acute hepatitis C.

Allison Venner1, Martin Kistin.   

Abstract

A 42-year-old woman developed epigastric abdominal pain and acutely elevated serum transaminase levels during a course of chemotherapy for breast cancer. Serum antibodies to hepatitis A, B and C were not identified initially, but subsequently a high hepatitis C viral load was detected. Ultrasonic imaging of the liver was normal. Serum transaminase elevations resolved within 2 months, and, after 6 months without therapy, the hepatitis C viral load became undetectable.

Entities:  

Mesh：

Year:  2014        PMID： 24549834     DOI： 10.1007/s10620-014-3068-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  9 in total

1.  When and how to treat acute hepatitis C?

Authors:  Anna Licata; Danilo Di Bona; Filippo Schepis; Lillian Shahied; Antonio Craxí; Calogero Cammà
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083

Review 2.  Acute hepatitis C virus infection: a chronic problem.

Authors:  Jason T Blackard; M Tarek Shata; Norah J Shire; Kenneth E Sherman
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 3.  Acute hepatitis C: current status and remaining challenges.

Authors:  Teresa Santantonio; Johannes Wiegand; J Tilman Gerlach
Journal:  J Hepatol       Date:  2008-07-17       Impact factor: 25.083

4.  The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.

Authors:  R Loomba; M M Rivera; R McBurney; Y Park; V Haynes-Williams; B Rehermann; H J Alter; S K Herrine; T J Liang; J H Hoofnagle; T Heller
Journal:  Aliment Pharmacol Ther       Date:  2010-12-29       Impact factor: 8.171

5.  Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.

Authors:  Parag Mahale; Dimitrios P Kontoyiannis; Roy F Chemaly; Ying Jiang; Jessica P Hwang; Marta Davila; Harrys A Torres
Journal:  J Hepatol       Date:  2012-08-04       Impact factor: 25.083

6.  Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.

Authors:  Sanaa M Kamal; Amr E Fouly; Refaat R Kamel; Bridgette Hockenjos; Ahmed Al Tawil; Khalifa E Khalifa; Qi He; Margaret J Koziel; Khairy M El Naggar; Jens Rasenack; Nezam H Afdhal
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

7.  Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report.

Authors:  Ivan Gentile; Alfonso De Stefano; Giusy Di Flumeri; Antonio Riccardo Buonomo; Chiara Carlomagno; Filomena Morisco; Sabino De Placido; Guglielmo Borgia
Journal:  In Vivo       Date:  2013 Jul-Aug       Impact factor: 2.155

Review 8.  Case definitions for acute hepatitis C virus infection: a systematic review.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  J Hepatol       Date:  2012-07-14       Impact factor: 25.083

9.  Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.

Authors:  Charlotte H B S van den Berg; Bart P X Grady; Janke Schinkel; Thijs van de Laar; Richard Molenkamp; Robin van Houdt; Roel A Coutinho; Debbie van Baarle; Maria Prins
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.